Daniel Kraft, M.D.

Daniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur, and innovator and is serving as the Chair of the XPRIZE Pandemic & Health Alliance. With over 25 years of experience in clinical practice, biomedical research, and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008, and in 2011 founded Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He was named one of the "Most Influential Voices in Healthcare for 2022" by Medika Life and was recognized by Forbes in 2023 as one of the "5 Futurists to Watch in Uncertain Times."

Following undergraduate degrees from Brown University and medical school at Stanford, Kraft was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology, and bone marrow transplantation at Stanford.

Kraft is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and a member of the Kaufman Fellows Society. He is a partner with Continuum Health Ventures which is focused on funding early stage digital health companies enabling the democratization of health and improved healthspan.

He has multiple scientific publications (including in Nature and Science) and medical device, immunology, and stem cell-related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.

Kraft's academic research has focused on stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. His clinical work has focused on bone marrow/hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell-based regenerative medicine, including marrow-derived stem cell harvesting, processing, and delivery.

He is heavily involved in digital health, founded Digital.Health, and is on the board of Healthy.io and advises several Fortune-50 and digital health-related startups. Kraft recently founded IntelliMedicine, focused on personalized, data-driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies.

Kraft is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.